Fasenra 00310-1730-85

Generic: Benralizumab

Package NDC

00310-1730-85

Manufacturer: Astrazeneca Pharmaceuticals Lp
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 14, 2017
Listing Expires: December 31, 2027
Application: BLA761070

Need to source Fasenra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Benralizumab	30 mg/mL

Drug Class

Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]

Selected Package

00310-1730-85Selected

1 SYRINGE, GLASS in 1 CARTON (0310-1730-85) / 1 mL in 1 SYRINGE, GLASS

Other packages for this product(1)

00310-1730-30

1 SYRINGE, GLASS in 1 CARTON (0310-1730-30) / 1 mL in 1 SYRINGE, GLASS

View →